BioSerenity provides remote monitoring and diagnostic software for healthcare sectors.
BioSerenity souhaite aider la communauté scientifique à mieux comprendre l'épilepsie pour mieux la soigner. Une fois anonymisées et privées de tout lien avec le patient, les données recueillies seront mise à disposition des chercheurs de l'Institut du Cerveau et de la Moelle épinière (ICM). C'est un pas décisif pour faire avancer la recherche sur l'épilepsie et améliorer le futur du diagnostic
BioSerenity may be growing as it has recently secured a significant amount of funding, specifically €24M, which is indicative of investor confidence and financial backing to support its operations and development. This capital infusion is likely to be allocated towards enhancing their AI diagnostic capabilities, which can lead to an expansion of their product offerings and potentially increase their market share in the healthcare sector. Furthermore, the investment suggests that BioSerenity is in a position to scale its remote monitoring and diagnostic software solutions, which is a positive sign of growth within the health diagnostics and medical device industry.
Director of Psychiatric Activity | 2019-03-01
Founder & Chief Executive Officer | 2014-01-01
Manager of Alliance | 2018-08-01
General Manager | 2020-03-01
Senior Data Scientist | 2019-10-01
IPhone / Mobile Compatible
Viewport Meta
Domain Not Resolving
Google Tag Manager
Apple Mobile Web Clips Icon
Google Font API
Google Maps
WordPress
Mobile Non Scaleable Content
US Privacy User Signal Mechanism
Coming soon
No similar companies found